GlassScriptPhysician profile
Fadi A Matar
NPI 1679512479
$33,493.07
in general payments reported to CMS, 2019-2025
21 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $604 · 2021: $1,330 · 2022: $2,348 · 2023: $1,519 · 2024: $2,629 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Food and Beverage: $4,314 · Entertainment: $33.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,297.47 |
| Food and Beverage | $4,314.26 |
| Entertainment | $33.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $12,560.84 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $8,606.65 | 2019 | |
| Abbott Laboratories | $3,674.66 | 2019-2025 | Coroflow, Xience Skypoint, Mitraclip |
| Edwards Lifesciences Corporation | $1,664.72 | 2024-2025 | Evoque, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Medtronic, INC. | $1,615.78 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Ancora Heart, INC. | $1,543.95 | 2021-2025 | Accucinch |
| Medtronic Vascular, INC. | $1,409.11 | 2019 | |
| Abiomed | $728.60 | 2020-2025 | Impella |
| Boston Scientific Corporation | $596.70 | 2019-2025 | General - Therapies, Watchman Flx, Sentinel |
| Recor Medical INC | $211.85 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Opsens INC. | $141.73 | 2022-2023 | Optowire |
| Gentuity, LLC | $116.67 | 2021 | |
| Heartflow, INC. | $115.91 | 2024 | |
| Philips North America LLC | $115.28 | 2023 | |
| Cvrx, INC. | $110.81 | 2020-2023 | Barostim Neo System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $94.73 | 2024 | 1788 |
| Shockwave Medical, INC | $65.58 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ablative Solutions, INC. | $39.72 | 2019 | |
| Penumbra, INC. | $38.46 | 2022-2023 | Indigo System |
| Astellas Pharma US INC | $23.95 | 2021 | |
| Livanova USA, INC. | $17.37 | 2023 | Lifesparc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Matar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.